NASDAQ:STAB
Statera Biopharma, Inc. Stock Forecast
$0.0007
+0 (+0%)
At Close: May 01, 2024
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Notice: Technical analysis is hidden due to insufficient data.
There can be multiple reasons for our algorithm to not provide conclusion. One of them can be low or no liquidity.
If you think this is not correct, please
FAQ
What is the symbol for Statera Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for Statera Biopharma, Inc. is STAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).
Should I buy or sell Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.
How to buy Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Statera Biopharma, Inc. Stock.
Click here for our free guide on how to buy Statera Biopharma, Inc. Stock.
What's the current price of Statera Biopharma, Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Statera Biopharma, Inc. (STAB) share was $0.0007.
What is the 52-week high and low for Statera Biopharma, Inc. Stock?
The 52-week high for Statera Biopharma, Inc. Stock is $0.0380 and the 52-week low is $0.000001.
What is the market capitalization of Statera Biopharma, Inc. Stock?
As of the May 01, 2024, the market capitalization of Statera Biopharma, Inc. is 49.991K.
When is the next earnings date for Statera Biopharma, Inc.?
The upcoming earnings date for Statera Biopharma, Inc. is May 17, 2024.